Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 45, Issue 1, 1998, Pages 41-48

  Kawashima, Yoshiaki ^a   Yamamoto, Hiromitsu ^a   Takeuchi, Hirofumi ^a   Hino, Tomoaki ^a   Niwa, Toshiyuki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

DL lactide glycolide copolymer; Elcatonin; Emulsion solvent diffusion method; Nanosphere; Tyrotropin releasing hormone

Indexed keywords

ELCATONIN; NANOPARTICLE; PEPTIDE HORMONE; POLYGLACTIN; PROTIRELIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; EMULSION; ENCAPSULATION; PHASE SEPARATION;

EID: 0031808981     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00121-5     Document Type: Article

References (12)

1. Ogawa Y., Okada H., Yamamoto M., Shimamoto T. In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lactic/glycolic) acids and in vivo degradation of these polymers. Chem. Pharm. Bull. 36:1988;1095-1103.
2. Okada H., Doken Y., Ogawa Y. Persistent suppression of the pituitary-gonadal system in female rats by 3-month depot injectable microspheres of leuprorelin acetate. J. Pharm. Sci. 85:1996;1044-1048.
3. Seijo B., Fattal E., Roblot-Treupel L., Couvreur P. Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading. Int. J. Pharm. 62:1990;1-7.
4. 14C-savoxepine loaded poly(DL-lactic acid) nanospheres to rats. J. Control. Release. 29:1994;97-104.
5. Uchida T., Martin S., Foster T.P., Wardley R.C., Grimm S. Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin. Pharm. Res. 11:1994;1009-1015.
6. Marcheal-Heussler L., Fessi H., Devissaguet J.P., Hoffman M., Maincent P. Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, polylactic-co-glycolic acid, poly-epsiloncaprolacton. S.T.P. Pharma Sci. 2:1992;98-104.
7. A.T. Florence, A.M. Hillery, H. Nasir, P.U. Jani, Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate, J. Control. Release 36 (1995) 39-46.
8. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. Preparations of biodegradable nanospheres of water soluble and insoluble drugs with DL-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J. Control. Release. 25:1993;89-98.
9. Niwa T., Takeuchi H., Hino T., Kunou N., Kawashima Y. In vitro drug release behavior of DL-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method. J. Pharm. Sci. 83:1994;727-732.
10. Niwa T., Takeuchi H., Hino T., Nohara M., Kawashima Y. Biodegradable submicron carriers for peptide drugs: preparation of DL-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. Int. J. Pharm. 121:1995;45-54.
11. Niwa T., Takeuchi H., Hino T., Kawashima Y. Stabilization of lactide/glycolide copolymer (PLGA) nanospheres with peptide-drug by freeze-drying. Yakuzaigaku. 55:1995;167-174.
12. Fessi H., Puisieux F., Devissaguet J.Ph., Ammoury N., Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:1989;R1-R4.